Entero therapeutics investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of entero therapeutics, inc. - ento

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed merger of entero therapeutics, inc. (nasdaqcm: ento) and journey therapeutics, inc. pursuant to the terms of the agreement, upon completion of the proposed transaction, journey shareholders will acquire 99% of the equity of entero. ksf is seeking to determine whether the merger and the process that led to it are adequ.
GM Ratings Summary
GM Quant Ranking